We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi Wins Injunction In Sun IP Suit Over Eloxatin

Law360 (February 17, 2011, 8:53 PM EST) -- Sanofi-Aventis LLC won a preliminary injunction barring Sun Pharmaceuticals Industries Ltd. from selling a generic version of Sanofi's colon cancer drug Eloxatin, after an agreement between the parties to temporarily halt...
To view the full article, register now.